Showing results (61-70 of 537) with videos related to
Sort By:
Pageof 54
Neuropsychopharmacology Reports|May 2, 2019
Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8-week, double-blind, multicenter, randomized controlled studyPhilip D Harvey, Hiroshi Nakamura, Mitsukuni MurasakiCNS Spectrums|September 8, 2017
Tardive dyskinesia: motor system impairments, cognition and everyday functioningMartin Strassnig, Amie Rosenfeld, Philip D HarveySchizophrenia Bulletin|May 23, 2008
Implementation considerations for multisite clinical trials with cognitive neuroscience tasksRichard S E Keefe, Philip D HarveyHandbook of Experimental Pharmacology|May 16, 2015
Methods for delivering and evaluating the efficacy of cognitive enhancementPhilip D Harvey, Richard S E KeefeCognitive Neuropsychiatry|June 10, 2015
Factors influencing self-assessment of cognition and functioning in bipolar disorder: a preliminary studyPhilip D Harvey, Gayla Paschall, Colin DeppHandbook of Experimental Pharmacology|October 3, 2012
Cognitive impairment in schizophreniaRichard S E Keefe, Philip D HarveySchizophrenia Research|June 6, 2015
The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: an analysis of the CATIE Schizophrenia TrialHenry A Glick, Pengxiang Li, Philip D HarveyThe American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 22, 2018
Associations of Age and Gender with Negative Symptom Factors and Functioning Among Middle-Aged and Older Adults with SchizophreniaAnjana Muralidharan, Philip D Harvey, Christopher R BowieJournal of Clinical and Experimental Neuropsychology|January 26, 2012
The influence of demographic factors on functional capacity and everyday functional outcomes in schizophreniaFelicia Gould, Christopher R Bowie, Philip D HarveyPsychopharmacology|November 15, 2003
Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorderPhilip D Harvey, Cynthia O Siu, Steven RomanoPageof 54